Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Shandong Weigao Group Medical Polymer Co ( (HK:1066) ) just unveiled an update.
Shandong Weigao Group Medical Polymer Co., Ltd. has announced a transaction involving its subsidiary, WEGO Prefills. Weigao Blood Purification will acquire 100% equity interest in WEGO Prefills, and in exchange, will issue Consideration Shares to the shareholders. This transaction may lead to Weigao Blood Purification becoming a non-wholly-owned subsidiary of the company, potentially affecting its financial consolidation. The transaction is significant under the Listing Rules, requiring reporting and shareholder approval due to its classification as a major and connected transaction.
The most recent analyst rating on (HK:1066) stock is a Hold with a HK$6.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.
More about Shandong Weigao Group Medical Polymer Co
Shandong Weigao Group Medical Polymer Co., Ltd. is a company based in China, operating in the medical polymer industry. It focuses on producing medical devices and related products, with a market focus on healthcare solutions.
Average Trading Volume: 15,733,873
Technical Sentiment Signal: Sell
Current Market Cap: HK$24.24B
For detailed information about 1066 stock, go to TipRanks’ Stock Analysis page.